MPLT
MapLight Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.00
+3.90%0
Insider buys (3m)
6
Insider sells (3m)
-$1.1M
Net value (3m)
-77.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 16, 2026 | Kreitzer Anatol · officer: Chief Discovery Officer | Sale | 12,248 | $7.84 |
| Oct 16, 2026 | GILLIS JONATHAN · officer: CAO and Interim CFO | Sale | 10,167 | $8.08 |
| Oct 16, 2026 | Lillie James Woodruff · officer: Chief Scientific Officer | Sale | 11,513 | $8.08 |
| Oct 16, 2026 | Hanson Kristopher · officer: General Counsel | Sale | 9,020 | $8.08 |
| Oct 16, 2026 | Foff Erin Pennock · officer: Chief Medical Officer | Sale | 15,355 | $8.08 |
| Oct 16, 2026 | Kroeger Christopher A. · director, officer: Chief Executive Officer | Sale | 73,691 | $8.08 |
Institutional positioning
13F filings over the trailing two quarters
New 57Increased 45Reduced 45Sold out 13
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Novo Holdings A/S | Unchanged | 3,686,622 | Aug 14, 2026 |
| NOVO HOLDINGS A/S | Unchanged | 3,686,622 | May 15, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3,226,400 | May 15, 2026 |
| FCPM III SERVICES B.V. | Unchanged | 3,226,400 | Aug 14, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Reduced | 2,801,937 | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | Reduced | 2,781,728 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,994,873 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,948,312 | Aug 14, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 1,422,935 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 1,339,731 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 1,025,134 | Aug 7, 2026 |
| BLUE OWL CAPITAL HOLDINGS LP | Increased | 1,005,929 | May 14, 2026 |
| NAN FUNG GROUP HOLDINGS LTD | Unchanged | 971,253 | May 14, 2026 |
| Nan Fung Group Holdings Ltd | Unchanged | 971,253 | Aug 13, 2026 |
| 5AM Venture Management, LLC | Unchanged | 950,011 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 16, 2026